Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661
Study Type: Treatment
Phase: II
NCTID: NCT02960022
Principal Investigator:
Rahul Parikh
A Phase I/II, Open Label, Single Arm, Two Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti Tumor Activity of glofitamab in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-cell Non-Hodgkin Lymphoma
Study Type: Treatment
Phase: I/II
NCTID: NCT05533775
Principal Investigator:
Kevin Ginn
The Cancer Tracking System CATSystem: A Randomized control trial to evaluate a systems level intervention for cervical cancer screening, treatment, referral and follow up in Kenya.
Study Type: Screening
Phase: N/A
NCTID: NCT06286462
Principal Investigator:
Sarah Kessler
A Phase 1/2 Trial of CBL0137 NSC 825802, IND 155843 in Patients with Relapsed or Refractory Solid Tumors including CNS Tumors and Lymphoma
Study Type: Treatment
Phase: I/II
NCTID: NCT04870944
Principal Investigator:
Kevin Ginn
A Phase II, Open-Label, Parallel Cohort Study Of Subcutaneous Amivantamab In Multiple Regimens In Patients With Advanced Or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer PALOMA-2
Study Type: Treatment
Phase: II
NCTID: NCT05498428
Principal Investigator:
Chao Huang
Blue Light Cystoscopy with Cysview Patient Registry
Study Type: Other
Phase: N/A
NCTID: NCT02660645
Principal Investigator:
John Taylor
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers ICONIC
Study Type: Treatment
Phase: II
NCTID: NCT03866382
Principal Investigator:
Elizabeth Wulff
Prospective evaluation of outcomes for HER2-positive breast cancer PRO-HER2
Study Type: Other
Phase: N/A
NCTID: NCT06603597
Principal Investigator:
Priyanka Sharma
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score
Study Type: Treatment
Phase: III
NCTID: NCT05879926
Principal Investigator:
Lauren Nye
A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukemia
Study Type: Treatment
Phase: I/II
NCTID: NCT05756322
Principal Investigator:
Tara Lin